Department of Microbiology, Immunology, & Pathology

Microbiology, Immunology,
and Pathology

Degree Programs

Graduate Programs

Certificate Program Graduate Certificate in Vector-Borne Diseases Master of Science in Microbiology Master of Science in Microbiology Master of Science in Microbiology [Thesis] Master of Science in Microbiology Microbiology-Immunology [Online] Ph.D. in Microbiology Ph.D. in Pathology

Undergraduate Programs

Bachelor of Science in Biomedical Sciences Microbiology and Infectious Disease Concentration Minor in Microbiology Certificate Program Undergraduate Certificate in Vector-Borne Diseases

Residencies and Externships

Combined Anatomic Pathology Residency and M.S./Ph.D. Combined Clinical Pathology Residency and M.S./Ph.D. Combined Comparative Medicine Residency and M.S./Ph.D. Combined Microbiology Residency and Ph.D.

View Available Externships

Areas of Expertise

Our faculty work to understand the pathology, improve the diagnostics, and develop more effective treatments, vaccines, and cures for internationally important infectious diseases.

Anatomic Pathology Bacteriology Cancer Biology Clinical Diagnostics Clinical Pathology Computational Biology Education Research Genomics Hematopathology Immunology Microbiome Mycobacterial Diseases Parasitology Pedagogy Prion Biology RNA Biology Vector Biology Virology

Centers and Institutes View All

news and updates view all

Cancer therapy meeting key safety checkpoints in human trial

A new treatment for pediatric osteosarcoma is clearing important safety hurdles in a phase 1 human clinical trial, a critical step in ongoing efforts by researchers at Colorado State University to develop a drug therapy for an aggressive form of bone cancer that kills hundreds of children each year.

CSU Ph.D. students earn prestigious PEO Scholarships

Two Colorado State University graduate students, including MIP’s Delaney Worthington, have earned a highly competitive scholarship honoring women’s contributions to research excellence.

AAC&U: Raymond Goodrich -Testing a promising new cancer immunotherapy in ovarian cancer patients

Ray Goodrich, professor in the Department of Microbiology, Immunology and Pathology, chats with AAC&U about a promising new cancer immunotherapy in ovarian cancer patients.

Support Microbiology, Immunology, and Pathology The Department of Microbiology, Immunology, and Pathology comprises more than 450 individuals who share a common passion for solving some of the most important human and animal health problems today. Your gift will support our students, faculty, and research. Give Now